Resultados de la búsqueda 211-220 of 11171 for Hepatitis b
The purpose of this study is to provide access to CTL019 through Managed Access Program (MAP) for acute lymphoblastic leukemia (ALL) or diffuse large b-cell ...
Hepatitis B vaccine: What to know to protect yourself Jan. 22, 2024, 03:30 p.m. CDT · Mayo Clinic Minute: Winter skin protection tips Jan. 19, 2024, 04:20 ...
gado, Várices esofágicas, Hepatitis C, Colangitis esclerosante primaria, Hepatitis B, Cáncer del conducto biliar, Hipertensión portal, Hemocromatosis ...
Also want to find out if kidney tumor treatment leads to an improvement in these immune markers. A Study of Hematopoiesis in Patients with Monoclonal B Cell ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
... B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and ...
The rationale for using MUC1-stimulated T-cells to treat multiple myeloma is twofold. The first is that T-cell therapies have been shown to be active in myeloma ...
... hepatitis B, varicela, enfermedad neumocócica, hepatitis A y rotavirus. ... Por ejemplo, algunos bebés pueden estar expuestos a un virus llamado hepatitis B ...
... B) of CA-4948 in patients with RR NHL with and without myeloid differentiation primary response 88 (MYD88) mutations. During Part B, patients will be ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?